Table of Contents As filed with the U.S. Securities and Exchange Commission on March 13, 2026. Registration No. 333-290086 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 2 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OPTIMI HEALTH CORP. (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's Name into English) (State or other jurisdiction of incorporation or organization) British Columbia 2834 Not Applic ...

Core Insights - Lifecore Biomedical, Inc. will report its financial results for the fourth quarter and transition period ended December 31, 2025, on March 16, 2026, before market opening [1] - A webcast hosted by Lifecore's senior management team will take place at 8:30 a.m. Eastern Time on the same day to discuss the results [1] Company Overview - Lifecore Biomedical, Inc. is a fully integrated injectables contract development and manufacturing organization (CDMO) specializing in the development, fill, and finish of sterile injectable pharmaceutical products [3] - The company has over 40 years of expertise in manufacturing premium, injectable-grade hyaluronic acid and serves global and emerging biopharmaceutical and biotechnology companies across various therapeutic categories [3]

Core Viewpoint - The Indian stock market, represented by the Sensex and Nifty indices, experienced a significant decline due to escalating tensions in West Asia and rising crude oil prices, which negatively impacted market sentiment [1][7]. Market Performance - The 30-share BSE Sensex fell by 1,097 points, or 1.37%, closing at 78,918.90, with an intraday low of 78,812.18, down 1,203.72 points or 1.50% [4] - The 50-share NSE Nifty dropped 315.45 points, or 1.27%, ending at 24,450.45 [4] - Major laggards in the Sensex included Eternal, ICICI Bank, Axis Bank, UltraTech Cement, HDFC Bank, State Bank of India, Bajaj Finserv, and Larsen & Toubro [4] Sector Performance - Gainers in the market included Bharat Electronics, Reliance Industries, Sun Pharma, NTPC, Infosys, and HCL Tech [5] Oil Price Impact - Brent crude oil prices increased by 2.53% to USD 87.57 per barrel, contributing to the market's decline [5][8] - Rising oil prices are expected to negatively affect India's deficits, inflation, and the Reserve Bank of India's monetary policy [7][8] Investment Trends - Foreign Institutional Investors (FIIs) sold equities worth Rs 3,752.52 crore, while Domestic Institutional Investors (DIIs) purchased stocks worth Rs 5,153.37 crore [10] - The previous session saw a rebound in the Sensex, which rose by 899.71 points, or 1.14%, to settle at 80,015.90, breaking a four-day decline [10]

Group 1 - Indian shares are expected to open higher following the US Supreme Court's ruling against Trump's tariffs, which has led to a temporary increase in tariffs on US imports from 10% to 15% [1][2] - The Indian trade delegation's plans to visit Washington have been delayed due to the uncertainty surrounding tariffs, which were intended to finalize an interim trade deal [3] - Domestic equities are anticipated to start positively, with export-oriented sectors likely to benefit from supportive trade developments [4] Group 2 - IDFC First Bank may experience a decline after announcing an investigation into a suspected fraud of $65 million involving local government accounts [5] - RailTel has received a letter of intent for a modernization project in Maharashtra valued at 11.36 billion rupees ($125.2 million) [7] - Vikram Solar has signed a 20 billion-rupee agreement with Jupiter International to procure 2 GW of solar cells [7]

Core Points - The Supreme Court ruled that tariffs imposed under the International Emergency Economic Powers Act (IEEPA) exceeded President Trump's authority, leading to the removal of a significant batch of tariffs [1][6] - Tariffs enacted under Section 232 of the Trade Expansion Act of 1962, aimed at protecting U.S. national security, remain in effect [2] Automotive Industry - Foreign vehicles and auto parts are still subject to a 25% tariff, which was implemented to encourage U.S. manufacturing [4] - Automakers are facing substantial financial impacts due to these tariffs, with Mercedes-Benz reporting a $1.2 billion hit to earnings in 2025 [5] - Ford anticipates a tariff bill similar to last year's $2 billion, while General Motors expects a $3.1 billion charge in 2025 and an additional $3 billion to $4 billion in 2026 [7] Furniture Industry - The furniture sector is affected by a 25% tariff on upholstered couches, kitchen cabinets, and vanities, which is set to increase to 50% in 2027 [11] - This industry is particularly sensitive to tariffs due to the high volume of imported goods [11] Steel and Aluminum Industry - Steel and aluminum imports continue to face a 50% tariff, impacting companies in home appliances, electronics, and beverage industries [13] Semiconductor Industry - A 25% tariff on certain semiconductors and chipmaking equipment remains in place, which took effect last month [14] Pharmaceutical Industry - While tariffs as high as 250% on pharmaceuticals have been avoided, there is potential for future tariffs under Section 232 if agreements with drugmakers are reversed [15][16] - Major pharmaceutical companies have agreed to lower drug prices to avoid tariffs for at least three years [16]

Core Insights - The 2026 Fortune World's Most Admired Companies list emphasizes the importance of reputation management and the ability to navigate constant change, highlighting that innovation is now a survival reflex based on human trust [1][2]. Company Rankings - The top companies in the 2026 list include: 1. Apple 2. Microsoft 3. Amazon.com 4. Nvidia 5. JPMorgan Chase 6. Berkshire Hathaway 7. Costco Wholesale 8. Alphabet 9. Walmart 10. American Express 11. Delta Air Lines 12. Netflix 13. Coca-Cola 14. Marriott International 15. Walt Disney 16. Goldman Sachs Group 17. Eli Lilly 18. FedEx 19. Procter & Gamble 20. Salesforce 21. Home Depot 22. BlackRock 23. Toyota Motor 24. Singapore Airlines 25. Nike 26. BMW 27. USAA 28. Starbucks 29. Johnson & Johnson 30. Morgan Stanley 31. Bank of America 32. IBM 33. Accenture 34. Caterpillar 35. Visa 36. Taiwan Semiconductor 37. Samsung Electronics 38. ServiceNow 39. Danaher 40. Mastercard 41. L'Oréal 42. Lowe's Companies, Inc. 43. UPS 44. GE Aerospace 45. Airbus 46. Pfizer 47. Lockheed Martin 48. Advanced Micro Devices (AMD) 49. Workday 50. Publix Super Markets [3][4]. Case Studies - **Walmart (No. 9)**: Walmart has transformed retail by leveraging its physical presence as an innovation asset, introducing the "Agentic AI" assistant, Sparky, to manage grocery budgets and meal planning. This approach has allowed 1.5 million associates to focus on higher-value tasks rather than inventory scanning [5][6]. - **Eli Lilly (No. 17)**: Eli Lilly's ascent into the top 20 is attributed to its partnership with Nvidia to create a powerful AI supercomputer, enhancing the customer experience through "LillyDirect," which streamlines access to medications [7]. - **Nvidia (No. 4)**: Nvidia's rise is linked to its culture of openness and collaboration, where learning is encouraged as a collective effort, allowing the company to outpace competitors in innovation [8]. - **Singapore Airlines (No. 24)**: The airline has invested $1.1 billion in retrofitting its Airbus A350 fleet with satellite internet, addressing the digital isolation of long-haul travel and enhancing the passenger experience [9][10]. Innovation Multiplier - The concept of the "Innovation Multiplier" is crucial for companies on the list, emphasizing the ability to apply new technologies to existing problems to create sustainable value. Companies like Apple maintain their top positions by delivering human-centered technology solutions [12]. Ranking Methodology - The 2026 rankings were determined through a survey of 3,700 executives, directors, and analysts, evaluating companies on nine criteria, including innovation and social responsibility. A company must rank in the top half of its industry to be included [13].

Market Performance - The Tel Aviv Stock Exchange experienced a rise, with the Tel Aviv 35 Index increasing by 0.87% to a new record of 4,232.65 points [1] - The Tel Aviv 125 Index also reached a new record, rising by 0.83% to 4,202.51 points [1] - The BlueTech Global Index rose by 1.19% to 676.98 points [1] - The All Bond corporate bond index fell by 0.10% to 424.55 points [1] - Total turnover in equities was NIS 4.84 billion, while bond turnover was NIS 6.39 billion [1] Currency Exchange Rates - The shekel-dollar exchange rate was set 0.225% lower at NIS 3.098/$ [2] - The shekel-euro exchange rate decreased by 0.093% to NIS 3.668/€ [2] Notable Stock Movements - Enlight Renewable Energy led the market with a rise of 3.45% on the highest trading turnover [3] - Elbit Systems Ltd. saw a significant increase of 4.33%, marking the largest rise on the Tel Aviv 35 Index [3] - Other notable gainers included OPC Energy (up 4.19%), Strauss Group (up 2.74%), Tower Semiconductor Ltd. (up 3.99%), and Camtek (up 4.06%) [3] Declining Stocks - Azrieli Group experienced the largest decline on the Tel Aviv 35 Index, falling by 4.03% [4] - Nice saw a decrease of 1.95%, while Teva Pharmaceutical Industries Ltd. fell by 0.93% [4] - ICL reported a decline of 3.93% following its fourth quarter results [4]

Table of Contents As filed with the U.S. Securities and Exchange Commission on February 17, 2026. Registration No. 333-290086 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OPTIMI HEALTH CORP. (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's Name into English) British Columbia 2834 Not Applicable (State or other jurisdiction of incorporation or organi ...

Market Performance - The Tel Aviv 35 Index rose 0.25% to a new record of 4,196.30 points, while the Tel Aviv 125 Index increased by 0.09% to 4,168.12, also a new record [1] - The BlueTech Global Index fell by 0.02% to 669 points, and the All Bond corporate bond index decreased by 0.05% to 424.99 points [1] - Total turnover in equities reached NIS 4.45 billion, and in bonds, it totaled NIS 7.12 billion [1] Foreign Exchange Rates - The shekel-dollar rate was set 0.551% higher at NIS 3.105/$, and the shekel-euro rate increased by 0.306% to NIS 3.672/€ [2] Company Performances - Teva Pharmaceutical Industries Ltd. led the market with a rise of 1.99% on the highest trading turnover [3] - Enlight Renewable Energy saw a significant increase of 12.04% after reporting strong fourth quarter results [3] - Other notable gainers included Elbit Systems Ltd. (up 1.96%), Next Vision (up 0.78%), Ormat Technologies Inc. (up 4.21%), and Azrieli Group (up 4.08%) [3] Decliners - Camtek experienced the largest decline on the Tel Aviv 35 Index, falling by 4.39% [4] - Tower Semiconductor Ltd. decreased by 3.46%, and Nova Ltd. fell by 2.21% [4] - Other companies that saw declines include Nice (down 0.97%) and Harel Insurance, Investments and Financial Services (down 2.09%) [4]

Eric M. Green West Pharmaceutical Services, Inc. President & CEO, Chair of the Board Bob W. McMahon Senior VP & Chief Financial Officer Fourth-Quarter and Full-Year 2025 Earnings Call February 12, 2026 | 8 a.m. Eastern Time To participate on the call by asking questions to Management, please register in advance by clicking here. A replay of the webcast will be available on the Company's website for on the call. approximately 90 days after the event. Registered telephone participants will receive the dial-in ...